IP PHARMACEUTICALS INDIA PVT.LTD.
IP PHARMACEUTICALS INDIA PVT.LTD. is a MAHARASHTRA based PRIVATE LIMITED company, Registered at dated 20-JAN-2011 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of IP PHARMACEUTICALS INDIA PVT.LTD. is U24239MH2011PTC290919 and registration number is 290919.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies MUMBAI India. Authorized share capital of IP PHARMACEUTICALS INDIA PVT.LTD. is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
IP PHARMACEUTICALS INDIA PVT.LTD. has 1 directors ,
The registered Email address of IP PHARMACEUTICALS INDIA PVT.LTD. is prajeet.nair@pfizer.com and its registered address is THE CAPITAL, 1802/1901, PLOT NO. C -70, G BLOCK BANDRA KURLA COMPLEX, BANDRA (EAST) MUMBAI , MUMBAI CITY UNCLASSIFIED MH 400051 MAHARASHTRA MAHARASHTRA india 400051.
The current status of IP PHARMACEUTICALS INDIA PVT.LTD. shows as ACTIVE
COMPANY BASIC DETAILS
IP PHARMACEUTICALS INDIA PVT.LTD.
MUMBAI
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24239MH2011PTC290919
20-JAN-2011
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
400051
INDIA
THE CAPITAL, 1802/1901, PLOT NO. C -70, G BLOCK BANDRA KURLA COMPLEX, BANDRA (EAST) MUMBAI , MUMBAI CITY UNCLASSIFIED MH 400051
prajeet.nair@pfizer.com
DIRECTOR DETAILS
| DIN | Director Name | Designation | Appointment Date | |
|---|---|---|---|---|
| No Records. | ||||
Details Updated by Companies
Quick Links
- All Registered company of MAHARASHTRA
- Company Registered in MAHARASHTRA
- All Registered company of MUMBAI SUBUEBAN in MAHARASHTRA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.